» Articles » PMID: 20972425

GAPDH Mediates Nitrosylation of Nuclear Proteins

Overview
Journal Nat Cell Biol
Specialty Cell Biology
Date 2010 Oct 26
PMID 20972425
Citations 214
Authors
Affiliations
Soon will be listed here.
Abstract

S-nitrosylation of proteins by nitric oxide is a major mode of signalling in cells. S-nitrosylation can mediate the regulation of a range of proteins, including prominent nuclear proteins, such as HDAC2 (ref. 2) and PARP1 (ref. 3). The high reactivity of the nitric oxide group with protein thiols, but the selective nature of nitrosylation within the cell, implies the existence of targeting mechanisms. Specificity of nitric oxide signalling is often achieved by the binding of nitric oxide synthase (NOS) to target proteins, either directly or through scaffolding proteins such as PSD-95 (ref. 5) and CAPON. As the three principal isoforms of NOS--neuronal NOS (nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS)--are primarily non-nuclear, the mechanisms by which nuclear proteins are selectively nitrosylated have been elusive. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is physiologically nitrosylated at its Cys 150 residue. Nitrosylated GAPDH (SNO-GAPDH) binds to Siah1, which possesses a nuclear localization signal, and is transported to the nucleus. Here, we show that SNO-GAPDH physiologically transnitrosylates nuclear proteins, including the deacetylating enzyme sirtuin-1 (SIRT1), histone deacetylase-2 (HDAC2) and DNA-activated protein kinase (DNA-PK). Our findings reveal a novel mechanism for targeted nitrosylation of nuclear proteins and suggest that protein-protein transfer of nitric oxide groups may be a general mechanism in cellular signal transduction.

Citing Articles

Redox regulation, protein S-nitrosylation, and synapse loss in Alzheimer's and related dementias.

Oh C, Nakamura T, Zhang X, Lipton S Neuron. 2024; 112(23):3823-3850.

PMID: 39515322 PMC: 11624102. DOI: 10.1016/j.neuron.2024.10.013.


The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities.

Cordani M, Michetti F, Zarrabi A, Zarepour A, Rumio C, Strippoli R Neoplasia. 2024; 58:101076.

PMID: 39476482 PMC: 11555605. DOI: 10.1016/j.neo.2024.101076.


The Multifaceted Role of Endothelial Sirt1 in Vascular Aging: An Update.

Campagna R, Mazzanti L, Pompei V, Alia S, Vignini A, Emanuelli M Cells. 2024; 13(17.

PMID: 39273039 PMC: 11394039. DOI: 10.3390/cells13171469.


Inhibition of Sirtuin Deacylase Activity by Peroxynitrite.

Bohl K, Wynia-Smith S, Jones Lipinski R, Smith B Biochemistry. 2024; 63(19):2463-2476.

PMID: 39256054 PMC: 11524680. DOI: 10.1021/acs.biochem.4c00257.


Utilizing deep ocean water in yeast fermentation for enhanced mineral-rich biomass production and fermentative regulation by proteomics modulation.

Liu C, Zhang X, Yu T, Lee C Heliyon. 2024; 10(10):e31031.

PMID: 38778955 PMC: 11109828. DOI: 10.1016/j.heliyon.2024.e31031.


References
1.
Lipton S, Choi Y, Takahashi H, Zhang D, Li W, Godzik A . Cysteine regulation of protein function--as exemplified by NMDA-receptor modulation. Trends Neurosci. 2002; 25(9):474-80. DOI: 10.1016/s0166-2236(02)02245-2. View

2.
Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

3.
Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F . Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006; 127(6):1109-22. DOI: 10.1016/j.cell.2006.11.013. View

4.
Dudzinski D, Michel T . Life history of eNOS: partners and pathways. Cardiovasc Res. 2007; 75(2):247-60. PMC: 2682334. DOI: 10.1016/j.cardiores.2007.03.023. View

5.
Chen L, Feng Y, Zhou Y, Zhu W, Shen X, Chen K . Dual role of Zn2+ in maintaining structural integrity and suppressing deacetylase activity of SIRT1. J Inorg Biochem. 2009; 104(2):180-5. DOI: 10.1016/j.jinorgbio.2009.10.021. View